×
Sign in
Menu
Home
Resources
Back To Top
×
Contact the Presenter
×
Add To Cart
×
Test
European Lung Cancer Congress 2022
Final Programme PDF
Advanced Search
30.03.2022
31.03.2022
01.04.2022
02.04.2022
Controversy session
ESMO Colloquium
Educational session
Industry Satellite Symposium
Mini Oral session
Multidisciplinary Interactive session
Multidisciplinary Tumour Board
Proffered Paper session
Special Symposium
Young oncologists session
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
Congress Hall
09:15(1h 30m)
ESMO Colloquium supported by Eli Lilly and company - One tumour, many faces: Optimising testing, targeting and monitoring oncogene-addicted NSCLC beyond EGFR
08:00(1h)
Oligoprogression in Advanced NSCLC
11:15(1h 30m)
Personalized treatment of lung cancer brain metastases
15:10(1h 30m)
Proffered Paper session 2
17:00(1h)
Salvage surgery and RT
Forum Hall
11:15(1h 30m)
First line in non-oncogene addicted NSCLC
13:30(1h 30m)
Janssen Oncology - Evolving treatment options and practices in EGFR-mutant NSCLC
09:15(1h 30m)
Minimal residual disease, biological disease
17:00(1h)
New TNM classification: Anatomical vs biological
18:15(1h 30m)
Novartis
08:00(1h)
Surgery vs radiation therapy for stage III NSCLC in the context of immunotherapy
South Hall 2
13:30(1h 30m)
AstraZeneca - CNS disease management in EGFRm NSCLC
17:00(1h)
Mini Oral session 1
11:15(1h 30m)
More targets, more drugs, more choices, more conflicts
09:15(1h 30m)
Telemedicine in lung cancer: What to do in 2022?
18:15(1h 30m)
Thermo Fisher Scientific
08:00(1h)
YO session 1
×
Dialog
×
Sponsored Access
Access to the resources are offered to you by
ESMO Events